Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IQIYI Inc - ADR (IQ) vs Koninklijke Philips NV (PHG) Price & Performance

IQIYI Inc - ADRTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

IQIYI Inc - ADR vs Koninklijke Philips NV — how do they compare? IQIYI Inc - ADR trades at $1.02 (market cap $979.50M), while Koninklijke Philips NV trades at $24.38 (market cap $23.68B). The key difference: Koninklijke Philips NV is far larger — about 24.2× IQIYI Inc - ADR's market cap, and Koninklijke Philips NV pays a 4.21% dividend while IQIYI Inc - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold IQIYI Inc - ADR for 55 Days and Koninklijke Philips NV for 84 Days on average.

IQPHG
Market Cap
$979.50M$23.68B
Volume
1,962,9501,443,075
Sector
MediaHealth
52-Week High
$2.35$32.91
52-Week Low
$0.86$23.81
Typical Hold Time
55 Days84 Days
Enterprise Value
$2.47B$30.07B
Dividend Yield
—4.21%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IQIYI Inc - ADR

IQ trades at $1.015, up 0.5% on the day, with a neutral technical signal and bearish moving averages. The company reported a net loss of $206.31 million in 2025 despite beating EPS estimates in recent quarters. Revenue declined to $27.29 billion, and negative profit margins persist. Analyst sentiment is mixed with a 50% buy rating. Recent news highlights iQIYI's focus on AI-driven content, including new titles and revenue-sharing successes.

The outlook is cautious due to revenue contraction and recurring losses, though AI initiatives offer growth potential. Key risks include competitive pressures in streaming and reliance on Chinese market dynamics. Institutional ownership trends and earnings performance in upcoming quarters will be critical for stock direction.

Koninklijke Philips NV

PHG trades at $24.30, up 0.62% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Analyst consensus leans Hold (63.64%) while institutional activity remains active with recent purchases by Bank of America and Arrowstreet Capital.

The outlook balances recovery momentum against technical weakness. Investment opportunity lies in continued earnings improvement and new product launches, while risks include competitive pressures and the bearish technical trend. Debt levels remain manageable with debt-to-asset ratio at 25.44% as of 2025.

Returns comparison

Trailing returns across standard periods

About IQIYI Inc - ADR

iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.

Read more on IQ →

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →